Relations between nonmotor manifestations and motor disorders in patients with benign essential blepharospasm.
Anxiety
Blepharospasm
Depression
Dry eye
Sleep quality
Journal
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
21
01
2023
accepted:
05
06
2023
revised:
30
05
2023
medline:
27
11
2023
pubmed:
21
6
2023
entrez:
21
6
2023
Statut:
ppublish
Résumé
To evaluate the relations between nonmotor manifestations (dry eye, mood disorders, and sleep disturbance) and motor disorders in patients with benign essential blepharospasm (BEB), and to determine whether relieving motor disorders by botulinum neurotoxin can improve the nonmotor manifestations. In this prospective case series study, 123 BEB patients were enrolled for evaluations. Among them, 28 patients underwent botulinum neurotoxin therapy and attended another two postoperative visits at 1 month and 3 months. Motor severity was measured with Jankovic Rating Scale (JRS) and Blepharospasm Disability Index (BSDI). We assessed dry eye using OSDI questionnaire, Schirmer test, tear break-up time (TBUT), tear meniscus height, lipid layer thickness (LLT) and corneal fluorescence staining. Zung's Self-rating Anxiety and Depression Scale (SAS, SDS) and Pittsburgh Sleep Quality Index (PSQI) were for mood status and sleep quality evaluations. Patients with dry eye or mood disorders had higher JRS scores (5.78 ± 1.13, 5.97 ± 1.30) than those without (5.12 ± 1.40, 5.50 ± 1.16; P = 0.039, 0.019, respectively). BSDI values of patients with sleep disturbance (14.61 ± 4.71) was higher than those without (11.89 ± 5.44, P = 0.006). Correlations were found between JRS, BSDI and SAS, SDS, PSQI, OSDI, TBUT. Botulinum neurotoxin effectively relieved JRS, BSDI and improved PSQI, OSDI, TBUT, LLT (8.11 ± 5.81, 21.77 ± 15.76, 5.04 ± 2.15 s, 79.61 ± 24.11 nm) at the 1-month visit compared to baseline (9.75 ± 5.60, 33.58 ± 13.27, 4.14 ± 2.21 s, 62.33 ± 22.01 nm; P = 0.006, < 0.001, = 0.027, < 0.001, respectively). The BEB patients with dry eye, mood disorders, or sleep disturbance had more severe motor disorders. Motor severity was associated with the severity of the nonmotor manifestations. Relieving motor disorders by botulinum neurotoxin was effective in improving dry eye and sleep disturbance.
Identifiants
pubmed: 37341835
doi: 10.1007/s00417-023-06141-x
pii: 10.1007/s00417-023-06141-x
doi:
Substances chimiques
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3615-3623Subventions
Organisme : Innovative Research Group Project of the National Natural Science Foundation of China
ID : 82070924
Organisme : Innovative Research Group Project of the National Natural Science Foundation of China
ID : 82000855
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Defazio G, Hallett M, Jinnah HA, Conte A, Berardelli A (2017) Blepharospasm 40 years later. Mov Disord 32(4):498–509. https://doi.org/10.1002/mds.26934
doi: 10.1002/mds.26934
pubmed: 28186662
pmcid: 5941939
Jankovic J (1986) Blepharospasm with basal ganglia lesions. Arch Neurol 43(9):866–868. https://doi.org/10.1001/archneur.1986.00520090006004
doi: 10.1001/archneur.1986.00520090006004
pubmed: 3741202
Lawes-Wickwar S, McBain H, Hirani SP, Hurt CS, Dunlop N, Solly D, Crampton B, Newman SP, Ezra DG (2021) Which factors impact on quality of life for adults with blepharospasm and hemifacial spasm? Orbit (Amsterdam, Netherlands) 40(2):110–119. https://doi.org/10.1080/01676830.2020.1733028
doi: 10.1080/01676830.2020.1733028
pubmed: 32116098
Girach A, Vinagre Aragon A, Zis P (2019) Quality of life in idiopathic dystonia: a systematic review. J Neurol 266(12):2897–2906. https://doi.org/10.1007/s00415-018-9119-x
doi: 10.1007/s00415-018-9119-x
pubmed: 30460447
Huang XF, Wang KY, Liang ZH, Du RR, Zhou LN (2015) Clinical Analysis of Patients with Primary Blepharospasm: A Report of 100 Cases in China. Eur Neurol 73(5–6):337–341. https://doi.org/10.1159/000381707
doi: 10.1159/000381707
pubmed: 25997849
Defazio G, Abbruzzese G, Aniello MS, Di Fede R, Esposito M, Fabbrini G, Girlanda P, Liguori R, Marinelli L, Martino D, Morgante F, Santoro L, Tinazzi M, Berardelli A (2012) Eye symptoms in relatives of patients with primary adult-onset dystonia. Mov Disord 27(2):305–307. https://doi.org/10.1002/mds.24026
doi: 10.1002/mds.24026
pubmed: 22173654
Tsubota K, Fujihara T, Kaido M, Mori A, Mimura M, Kato M (1997) Dry eye and Meige’s syndrome. Br J Ophthalmol 81(6):439–442. https://doi.org/10.1136/bjo.81.6.439
doi: 10.1136/bjo.81.6.439
pubmed: 9274405
pmcid: 1722218
Lin T, Gong L (2016) In vivo confocal microscopy of meibomian glands in primary blepharospasm: A prospective case-control study in a Chinese population. Medicine 95(23):e3833. https://doi.org/10.1097/MD.0000000000003833
doi: 10.1097/MD.0000000000003833
pubmed: 27281086
pmcid: 4907664
Girard BC, Lévy P (2019) Dry eye syndrome in benign essential blepharospasm. J Fr Ophtalmol 42(10):1062–1067. https://doi.org/10.1016/j.jfo.2019.06.007
doi: 10.1016/j.jfo.2019.06.007
pubmed: 31733914
Fabbrini G, Berardelli I, Moretti G, Pasquini M, Bloise M, Colosimo C, Biondi M, Berardelli A (2010) Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord 25(4):459–465. https://doi.org/10.1002/mds.22983
doi: 10.1002/mds.22983
pubmed: 20108377
Broocks A, Thiel A, Angerstein D, Dressler D (1998) Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm. Am J Psychiatry 155(4):555–557. https://doi.org/10.1176/ajp.155.4.555
doi: 10.1176/ajp.155.4.555
pubmed: 9546005
Paus S, Gross J, Moll-Müller M, Hentschel F, Spottke A, Wabbels B, Klockgether T, Abele M (2011) Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study. J Neurol 258(10):1835–1840. https://doi.org/10.1007/s00415-011-6029-6
doi: 10.1007/s00415-011-6029-6
pubmed: 21499724
Yang J, Shao N, Song W, Wei Q, Ou R, Wu Y, Shang HF (2016) Nonmotor symptoms in primary adult-onset cervical dystonia and blepharospasm. Brain Behav 7(2):e00592. https://doi.org/10.1002/brb3.592
doi: 10.1002/brb3.592
pubmed: 28239516
pmcid: 5318359
Fahn S, Bressman SB, Marsden CD (1998) Classification of dystonia. Adv Neurol 78:1–10
doi: 10.1212/WNL.50.5_Suppl_5.S1
pubmed: 9750897
Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G (2009) Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 24(3):407–413. https://doi.org/10.1002/mds.22368
doi: 10.1002/mds.22368
pubmed: 19053054
Zung WW (1971) A rating instrument for anxiety disorders. Psychosomatics 12(6):371–379. https://doi.org/10.1016/S0033-3182(71)71479-0
doi: 10.1016/S0033-3182(71)71479-0
pubmed: 5172928
Zung WW (1965) A SELF-RATING DEPRESSION SCALE. Arch Gen Psychiatry 12:63–70. https://doi.org/10.1001/archpsyc.1965.01720310065008
doi: 10.1001/archpsyc.1965.01720310065008
pubmed: 14221692
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213. https://doi.org/10.1016/0165-1781(89)90047-4
doi: 10.1016/0165-1781(89)90047-4
pubmed: 2748771
Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol (Chicago, Ill. : 1960) 118(5):615–621. https://doi.org/10.1001/archopht.118.5.615
doi: 10.1001/archopht.118.5.615
Lemp MA (1995) Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 21(4):221–232
pubmed: 8565190
Lin T, Wang W, Lu Y, Gong L (2021) Treatment of Dry Eye With Intracanalicular Injection of Hydroxybutyl Chitosan: A Prospective Randomized Clinical Trial. Front Med 8:769448. https://doi.org/10.3389/fmed.2021.769448
doi: 10.3389/fmed.2021.769448
Marsden CD (1976) Blepharospasm-oromandibular dystonia syndrome (Brueghel’s syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry 39(12):1204–1209. https://doi.org/10.1136/jnnp.39.12.1204
doi: 10.1136/jnnp.39.12.1204
pubmed: 1011031
pmcid: 492566
Yu Z, Wu X, Zhu J, Jin J, Zhao Y, Yu L (2021) Trends in Topical Prescriptional Therapy for Old Patients With Dry Eye Disease in Six Major Areas of China: 2013–2019. Front Pharmacol 12:690. https://doi.org/10.3389/fphar.2021.690640
doi: 10.3389/fphar.2021.690640
Martino D, Defazio G, Alessio G, Abbruzzese G, Girlanda P, Tinazzi M, Fabbrini G, Marinelli L, Majorana G, Buccafusca M, Vacca L, Livrea P, Berardelli A (2005) Relationship between eye symptoms and blepharospasm: a multicenter case-control study. Mov Disord 20(12):1564–1570. https://doi.org/10.1002/mds.20635
doi: 10.1002/mds.20635
pubmed: 16092106
Lu R, Huang R, Li K, Zhang X, Yang H, Quan Y, Li Q (2014) The influence of benign essential blepharospasm on dry eye disease and ocular inflammation. Am J Ophthalmol 157(3):591–7.e72. https://doi.org/10.1016/j.ajo.2013.11.014
doi: 10.1016/j.ajo.2013.11.014
pubmed: 24269849
Ho RW, Fang PC, Chao TL, Chien CC, Kuo MT (2018) Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm. Sci Rep 8(1):8367. https://doi.org/10.1038/s41598-018-26750-5
doi: 10.1038/s41598-018-26750-5
pubmed: 29849166
pmcid: 5976660
Park DI, Shin HM, Lee SY, Lew H (2013) Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm. Acta Ophthalmol 91(2):e108–e112. https://doi.org/10.1111/aos.12002
doi: 10.1111/aos.12002
pubmed: 23425111
Sullivan DA, Rocha EM, Aragona P, Clayton JA, Ding J, Golebiowski B, Hampel U, McDermott AM, Schaumberg DA, Srinivasan S, Versura P, Willcox MDP (2017) TFOS DEWS II Sex, Gender, and Hormones Report. Ocul Surf 15(3):284–333. https://doi.org/10.1016/j.jtos.2017.04.001
doi: 10.1016/j.jtos.2017.04.001
pubmed: 28736336
Liu Y, Wang X, Sun P, Zhang Q, Zhang C, Shen Y, Wang S, Ma J, Wang G (2022) Sleep disturbance and anxiety symptom among public during the second wave of COVID-19 in Beijing: A web-based cross-sectional survey. J Affect Disord 298(Pt A):80–85. https://doi.org/10.1016/j.jad.2021.10.068
doi: 10.1016/j.jad.2021.10.068
pubmed: 34728284
Li M, Gong L, Sun X, Chapin WJ (2011) Anxiety and depression in patients with dry eye syndrome. Curr Eye Res 36(1):1–7. https://doi.org/10.3109/02713683.2010.519850
doi: 10.3109/02713683.2010.519850
pubmed: 21174591
Müller J, Kemmler G, Wissel J, Schneider A, Voller B, Grossmann J, Diez J, Homann N, Wenning GK, Schnider P, Poewe W, Austrian Botulinum Toxin and Dystonia Study Group (2002) The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol 249(7):842–846. https://doi.org/10.1007/s00415-002-0733-1
doi: 10.1007/s00415-002-0733-1
pubmed: 12140667
Lencer R, Steinlechner S, Stahlberg J, Rehling H, Orth M, Baeumer T, Rumpf HJ, Meyer C, Klein C, Muenchau A, Hagenah J (2009) Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry 80(10):1176–1179. https://doi.org/10.1136/jnnp.2008.170191
doi: 10.1136/jnnp.2008.170191
pubmed: 19465414
Lestingi S, Kim L, Gonçalves BDSB, Silva SMA, Ferraz H, Coelho FM, Borges V (2023) Blepharospasm Patients after Botulinum Toxin - Sleep Approach. Sleep Sci (Sao Paulo, Brazil) 16(1):38–43. https://doi.org/10.1055/s-0043-1767753
doi: 10.1055/s-0043-1767753